
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Dvl-1/Dishevelled 1/DVL1 CRISPR/Cas9 KO Plasmid (h) | sc-400785 | 20 µg | $397.00 |
DVL1 encodes Dishevelled 1 (Dvl-1), a cytoplasmic phosphoprotein that functions as a core scaffold in Wnt signal transduction. Dvl-1 integrates receptor-proximal inputs from Frizzled and co-receptors to propagate both β-catenin–dependent (canonical) and planar cell polarity/Wnt–Ca²⁺ (non-canonical) signaling, influencing cell polarity, migration, and transcriptional programs. Through its DIX, PDZ, and DEP domains, Dvl-1 coordinates multiprotein complexes that regulate β-catenin stabilization, small GTPase signaling, and cytoskeletal remodeling. Dysregulation of Wnt/Dishevelled signaling is frequently linked to altered developmental patterning and oncogenic pathway activation, making DVL1 a relevant node for mechanistic studies of pathway rewiring in disease-associated contexts.
Dvl-1/Dishevelled 1/DVL1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DVL1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the DVL1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the DVL1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Dvl-1/Dishevelled 1/DVL1 protein expression.
This CRISPR knockout system enables efficient generation of DVL1-deficient cell models for investigation of Dvl-1/Dishevelled 1/DVL1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.